Cardio Diagnostics Holdings, Inc. (CDIO)Healthcare | Biotechnology | Chicago, United States | NasdaqCM
1.75 USD
-0.03
(-1.691%) ⇩
(Oct. 13, 2026, 4 p.m.
EDT)
After hours: 1.88 +0.13 (7.429%) ⇧ (Oct. 13, 2026, 7:43 p.m. EDT) |
Hot Take ↕ | Oct. 10, 2026, 5:53 a.m. EDT
The immediate outlook remains flat due to a severe disconnect between the company's deteriorating financial reality and its recent promotional activity. While headlines celebrate AI innovations and strategic expansions, the underlying business is hemorrhaging value, evidenced by a massive 28% drop in revenue and catastrophic operating margins of -279%. The stock has suffered a brutal 98.6% decline over the last three years, with every single year showing negative growth, signaling a deep structural failure rather than a temporary setback. This multi-year collapse suggests the market has correctly identified that the current valuation is unjustified regardless of future potential. Furthermore, the lack of any dividend payout eliminates income appeal, leaving investors exposed to pure speculative risk in a biotech sector where cash burn is accelerating. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.192897 |
| MSTL | 0.213663 |
| AutoTheta | 0.216904 |
| AutoARIMA | 0.627501 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 36% |
| H-stat | 2.58 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.165 |
| Excess Kurtosis | -0.20 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 4.978 |
| Revenue per Share | 0.006 |
| Market Cap | 5,179,071 |
| Forward P/E | -7.00 |
| Beta | 2.24 |
| Website | https://cdio.ai |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.60575855 |
| Address1 | 311 West Superior Street |
| Address2 | Suite 444 |
| All Time High | 307.5 |
| All Time Low | 0.97 |
| Ask | 2.56 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 33,970 |
| Average Daily Volume3 Month | 57,241 |
| Average Volume | 57,241 |
| Average Volume10Days | 33,970 |
| Beta | 2.237 |
| Bid | 1.54 |
| Bid Size | 2 |
| Book Value | 2.509 |
| City | Chicago |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.75 |
| Current Ratio | 17.149 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,790,726,400 |
| Day High | 1.86 |
| Day Low | 1.75 |
| Debt To Equity | 4.978 |
| Display Name | Cardio Diagnostics |
| Dividend Yield | 0.0 |
| Earnings Timestamp End | 1,793,995,200 |
| Earnings Timestamp Start | 1,793,995,200 |
| Ebitda | -6,084,045 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.006 |
| Enterprise To Revenue | -2.625 |
| Enterprise Value | -37,928 |
| Eps Forward | -0.25 |
| Eps Trailing Twelve Months | -2.91 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.92098 |
| Fifty Day Average Change | -0.17097998 |
| Fifty Day Average Change Percent | -0.08900664 |
| Fifty Two Week Change Percent | -60.575855 |
| Fifty Two Week High | 7.91 |
| Fifty Two Week High Change | -6.16 |
| Fifty Two Week High Change Percent | -0.778761 |
| Fifty Two Week Low | 0.97 |
| Fifty Two Week Low Change | 0.78 |
| Fifty Two Week Low Change Percent | 0.80412364 |
| Fifty Two Week Range | 0.97 - 7.91 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,642,170,600,000 |
| Float Shares | 2,836,562 |
| Forward Eps | -0.25 |
| Forward P E | -7.0 |
| Free Cashflow | -3,773,845 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 15 |
| Fullday Change | 0.09990001 |
| Fullday Change Percent | 5.612045 |
| Fullday Price | 1.75 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 1.0 |
| Gross Profits | 14,450 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.08307 |
| Held Percent Institutions | 0.06522 |
| Implied Shares Outstanding | 2,959,469 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,747,094,400 |
| Last Split Factor | 1:30 |
| Long Business Summary | Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. The company offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment clinical blood test targeting CHD events, including heart attacks; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform that offers new epigenetic and genetic insights to clinicians prescribing to help improve chronic care management. It also provides CardioInnovate360, a research-use-only solution to support the discovery, development and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases; and HeartRisk, a SaaS cardiovascular disease risk intelligence platform. It serves telemedicine providers; provider organizations, such as concierge practices, longevity clinics, and risk-bearing provider organizations; and employer organizations. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois. |
| Long Name | Cardio Diagnostics Holdings, Inc. |
| Market | us_market |
| Market Cap | 5,179,071 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_1671478040 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -6,469,530 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 5,682,180 |
| Open | 1.86 |
| Operating Cashflow | -5,659,843 |
| Operating Margins | -279.50504 |
| Phone | 855 226 9991 |
| Post Market Change | 0.13 |
| Post Market Change Percent | 7.428571 |
| Post Market Price | 1.88 |
| Post Market Time | 1,791,935,033 |
| Previous Close | 1.7801 |
| Price Hint | 4 |
| Price To Book | 0.697489 |
| Price To Sales Trailing12 Months | 358.4132 |
| Profit Margins | 0.0 |
| Quick Ratio | 15.564 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.030099988 |
| Regular Market Change Percent | -1.6909156 |
| Regular Market Day High | 1.86 |
| Regular Market Day Low | 1.75 |
| Regular Market Day Range | 1.75 - 1.86 |
| Regular Market Open | 1.86 |
| Regular Market Previous Close | 1.7801 |
| Regular Market Price | 1.75 |
| Regular Market Time | 1,791,921,600 |
| Regular Market Volume | 19,737 |
| Return On Assets | -0.44055998 |
| Return On Equity | -0.75442004 |
| Revenue Growth | -0.283 |
| Revenue Per Share | 0.006 |
| Sand P52 Week Change | 0.17502642 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 2,959,469 |
| Shares Percent Shares Out | 0.00029999999 |
| Shares Short | 1,012 |
| Shares Short Previous Month Date | 1,788,134,400 |
| Shares Short Prior Month | 23,626 |
| Short Name | Cardio Diagnostics Holdings Inc |
| Short Percent Of Float | 0.00029999999 |
| Short Ratio | 0.03 |
| Source Interval | 15 |
| State | IL |
| Symbol | CDIO |
| Total Cash | 5,586,697 |
| Total Cash Per Share | 1.888 |
| Total Debt | 369,698 |
| Total Revenue | 14,450 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -2.91 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 2.13541 |
| Two Hundred Day Average Change | -0.38541007 |
| Two Hundred Day Average Change Percent | -0.18048528 |
| Type Disp | Equity |
| Volume | 19,737 |
| Website | https://cdio.ai |
| Zip | 60,654 |